📊 CBDW Key Takeaways
Investment Thesis
1606 Corp is in critical financial distress with negative stockholders equity of -$2.9M, indicating the company is technically insolvent. The company generated zero revenue in the latest period despite a 101.5% YoY increase claim, while burning $349.3K in operating cash flow and carrying $2.0M in long-term debt against only $14.6K in total assets. The combination of massive losses, negative working capital (0.01x current ratio), and inability to service debt makes this a value destruction vehicle.
CBDW Strengths
- Revenue growth claim of 101.5% YoY (though from near-zero baseline)
- Minimal asset base limits downside exposure for debt holders
- No insider selling pressure in last 90 days
CBDW Risks
- Negative stockholders equity indicates technical insolvency and high bankruptcy risk
- Cash reserves of only $998 with $2.9M liabilities create immediate liquidity crisis
- Negative operating cash flow of -$349.3K demonstrates inability to generate cash from core operations
- Zero revenue generation undermines viability of business model
- Current ratio of 0.01x indicates severe working capital deficiency
- Long-term debt of $2.0M with deteriorating equity cushion creates creditor risk
Key Metrics to Watch
- Cash balance and runway to insolvency
- Debt restructuring or covenant violation announcements
- Actual revenue recognition and path to profitability
- Changes in stockholders equity and potential recapitalization
CBDW Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CBDW Profitability Ratios
CBDW vs Technology Sector
How 1606 CORP. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CBDW Balance Sheet & Liquidity
CBDW 5-Year Financial Trend
5-Year Trend Summary: 1606 CORP.'s revenue has declined by 89% over the 5-year period, indicating business contraction. The most recent EPS of $-0.03 indicates the company is currently unprofitable.
CBDW Growth Metrics (YoY)
CBDW Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | N/A | -$384.5K | $0.00 |
| Q2 2025 | N/A | -$210.1K | $0.00 |
| Q1 2025 | N/A | -$208.3K | $0.00 |
| Q3 2024 | N/A | -$566.3K | N/A |
| Q2 2024 | N/A | -$339.2K | N/A |
| Q1 2024 | $1.2K | -$286.4K | N/A |
| Q3 2023 | $80 | -$119.0K | N/A |
| Q2 2023 | $304 | -$121.6K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CBDW Capital Allocation
CBDW SEC Filings
Access official SEC EDGAR filings for 1606 CORP. (CIK: 0001877461)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CBDW
What is the AI rating for CBDW?
1606 CORP. (CBDW) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CBDW's key strengths?
Revenue growth claim of 101.5% YoY (though from near-zero baseline). Minimal asset base limits downside exposure for debt holders.
What are the risks of investing in CBDW?
Negative stockholders equity indicates technical insolvency and high bankruptcy risk. Cash reserves of only $998 with $2.9M liabilities create immediate liquidity crisis.
What is CBDW's revenue and growth?
1606 CORP. reported revenue of $0.0.
Does CBDW pay dividends?
1606 CORP. does not currently pay dividends.
Where can I find CBDW SEC filings?
Official SEC filings for 1606 CORP. (CIK: 0001877461) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CBDW's EPS?
1606 CORP. has a diluted EPS of $-0.01.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.